GERN
USDGeron Corporation Common Stock
$1.150-0.050 (-4.167%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$1.200
Haut
$1.220
Bas
$1.140
Volume
8.19M
Fondamentaux de l'Entreprise
Capitalisation Boursière
733.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
7.83M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Bas $1.09Actuel $1.150Haut $4.5
Actualités Connexes
BusinessWire
Geron Corporation to Present at Upcoming Investor Conferences
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled
Voir plus
BusinessWire
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.